Differential responses to e-cig generated aerosols from humectants and different forms of nicotine in epithelial cells from nonsmokers and smokers

Am J Physiol Lung Cell Mol Physiol. 2021 Jun 1;320(6):L1064-L1073. doi: 10.1152/ajplung.00525.2020. Epub 2021 Apr 7.

Abstract

In the United States, millions of adults use electronic cigarettes (e-cigs), and a majority of these users are former or current cigarette smokers. It is unclear, whether prior smoking status affects biological responses induced by e-cigs. In this study, differentiated human nasal epithelial cells (hNECs) from nonsmokers and smokers at air-liquid interface were acutely exposed to the e-cig generated aerosols of humectants, propylene glycol (PG), and glycerol (GLY). Mucin levels were examined in the apical washes, and cytokine levels were assessed in the basolateral supernatants 24 h postexposure. The aerosol from the GLY exposure increased mucin 5, subtype AC (MUC5AC) levels in the apical wash of hNECs from nonsmokers, but not smokers. However, the aerosol from GLY induced pro-inflammatory responses in hNECs from smokers. We also exposed hNECs from nonsmokers and smokers to e-cig generated aerosol from PG:GLY with freebase nicotine or nicotine salt. The PG:GLY with freebase nicotine exposure increased MUC5AC and mucin 5, subtype B (MUC5B) levels in hNECs from nonsmokers, but the nicotine salt exposure did not. The PG:GLY with nicotine salt exposure increased pro-inflammatory cytokines in hNECs from smokers, which was not seen with the freebase nicotine exposure. Taken together, these data indicate that the e-cig generated aerosols from the humectants, mostly GLY, and the type of nicotine used cause differential effects in airway epithelial cells from nonsmokers and smokers. As e-cig use is increasing, it is important to understand that the biological effects of e-cig use are likely dependent on prior cigarette smoke exposure.

Keywords: GLY; PG; e-cigs; nicotine; smokers.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Electronic Nicotine Delivery Systems
  • Epithelial Cells / drug effects*
  • Glycerol / pharmacology
  • Humans
  • Hygroscopic Agents / pharmacology
  • Lung / drug effects
  • Nicotine / pharmacology*
  • Non-Smokers*
  • Propylene Glycol / pharmacology
  • Smokers*
  • Vaping / adverse effects*

Substances

  • Hygroscopic Agents
  • Propylene Glycol
  • Nicotine
  • Glycerol